Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

New-onset atrial fibrillation after surgical aortic valve replacement and transcatheter aortic valve implantation: a concise review

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. State of Transcatheter Aortic Valve Implantation in Spain Versus Europe and Non-European Countries

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Catheter Ablation of Focal Atrial Tachycardia Using Remote Magnetic Navigation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Reevaluation of the indications for permanent pacemaker implantation after transcatheter aortic valve implantation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Smokers with ST-segment elevation myocardial infarction and short time to treatment have equal effects of PCI and fibrinolysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Duration of Heart Failure and Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Mortality and morbidity of major congenital heart disease related to general prenatal screening for malformations

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Reappraisal of variants previously linked with sudden infant death syndrome: results from three population-based cohorts

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Clinical implications of electrocardiographic bundle branch block in primary care

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Surgical aortic valve replacement (SAVR) and, more recently, transcatheter aortic valve implantation (TAVI) have been shown to be the only treatments that can improve the natural cause of severe aortic valve stenosis. However, after SAVR and TAVI, the incidence of new-onset atrial fibrillation (NOAF) is 31%-64% and 4%-32%, respectively. NOAF is independently associated with adverse events such as stroke, death, and increased length of hospital stay. Increasing the knowledge of predisposing factors, optimal postprocedural monitoring, and prophylactic antiarrhythmic and antithrombotic therapy may reduce the risk of complications secondary to NOAF.

OriginalsprogEngelsk
TidsskriftThe Journal of invasive cardiology
Vol/bind27
Udgave nummer1
Sider (fra-til)41-7
Antal sider7
ISSN1042-3931
StatusUdgivet - jan. 2015

ID: 46182191